Is there evidence supporting the use of Fefol (elemental iron 46.8 mg) three times daily (tid) for treating iron‑deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Evidence Supports Fefol Three Times Daily (TDS) Dosing

Current evidence does not support using Fefol (elemental iron 46.8mg) three times daily for treating iron deficiency anemia. The 2021 British Society of Gastroenterology guidelines explicitly recommend once-daily dosing of 50-100 mg elemental iron as the optimal initial treatment approach 1.

Why TDS Dosing is Not Recommended

The evidence demonstrates that multiple daily doses of iron are counterproductive due to hepcidin physiology:

  • Single daily doses stimulate hepcidin, which then reduces iron absorption for the next 24 hours 1
  • 60 mg elemental iron once daily produces similar total absorption to 60 mg twice daily because the second dose is poorly absorbed 1
  • A randomized trial showed 60 mg twice daily produced faster Hb rise than alternate-day dosing, but this came at the cost of significantly more gastrointestinal side effects 1

The Optimal Dosing Strategy

Give 50-100 mg elemental iron once daily on an empty stomach 1. This represents the best balance between efficacy and tolerability.

For Fefol Specifically (46.8 mg elemental iron per dose):

  • One capsule daily would provide suboptimal dosing (below the 50-100 mg target)
  • Two capsules once daily (93.6 mg total) would be appropriate
  • Three times daily dosing (140.4 mg total) is excessive and will increase side effects without improving absorption

Alternative Approaches if Standard Dosing Fails

If once-daily dosing is not tolerated:

  1. Every-other-day dosing: Alternate-day administration significantly increases fractional iron absorption and reduces GI side effects (relative risk 0.56 for GI adverse events) 1. The 2024 AGA guidelines support this approach 2

  2. Lower the dose: Consider one Fefol capsule (46.8 mg) every other day for better tolerance

  3. Switch to parenteral iron: For patients with intolerance, malabsorption, or continued bleeding 1

Critical Monitoring Points

  • Check Hb at 2 weeks: Absence of ≥10 g/L rise predicts treatment failure (sensitivity 90.1%, specificity 79.3%) 1
  • Monitor every 4 weeks until Hb normalizes 1
  • Continue treatment for 2-3 months after Hb normalization to replenish iron stores 1

Common Pitfalls to Avoid

  • Don't prescribe multiple daily doses thinking "more is better" - this increases side effects without improving absorption
  • Don't switch between different iron salts for intolerance - this practice is not evidence-based 1
  • Don't ignore treatment failure at 2 weeks - this is highly predictive and should prompt investigation or switch to IV iron

The Bottom Line

Prescribe Fefol as 2 capsules once daily (93.6 mg elemental iron) rather than one capsule three times daily. If not tolerated, switch to every-other-day dosing or consider parenteral iron rather than continuing a TDS regimen that will only worsen side effects without improving outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.